466 related articles for article (PubMed ID: 28797647)
1. Matrix metalloproteinases: The sculptors of chronic cutaneous wounds.
Krishnaswamy VR; Mintz D; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2220-2227. PubMed ID: 28797647
[TBL] [Abstract][Full Text] [Related]
2. Targeting matrix metalloproteases to improve cutaneous wound healing.
Xue M; Le NT; Jackson CJ
Expert Opin Ther Targets; 2006 Feb; 10(1):143-55. PubMed ID: 16441234
[TBL] [Abstract][Full Text] [Related]
3. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.
Mirastschijski U; Impola U; Jahkola T; Karlsmark T; AGren MS; Saarialho-Kere U
Hum Pathol; 2002 Mar; 33(3):355-64. PubMed ID: 11979378
[TBL] [Abstract][Full Text] [Related]
4. Matrix remodeling by MMPs during wound repair.
Rohani MG; Parks WC
Matrix Biol; 2015; 44-46():113-21. PubMed ID: 25770908
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence.
Lazaro JL; Izzo V; Meaume S; Davies AH; Lobmann R; Uccioli L
J Wound Care; 2016 May; 25(5):277-87. PubMed ID: 27169343
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix contribution to skin wound re-epithelialization.
Rousselle P; Montmasson M; Garnier C
Matrix Biol; 2019 Jan; 75-76():12-26. PubMed ID: 29330022
[TBL] [Abstract][Full Text] [Related]
7. Expression and integrity of dermatopontin in chronic cutaneous wounds: a crucial factor in impaired wound healing.
Krishnaswamy VR; Manikandan M; Munirajan AK; Vijayaraghavan D; Korrapati PS
Cell Tissue Res; 2014 Dec; 358(3):833-41. PubMed ID: 25260909
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
Mirastschijski U; Impola U; Karsdal MA; Saarialho-Kere U; Agren MS
J Invest Dermatol; 2002 Jan; 118(1):55-64. PubMed ID: 11851876
[TBL] [Abstract][Full Text] [Related]
9. Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio.
Dang CM; Beanes SR; Lee H; Zhang X; Soo C; Ting K
Plast Reconstr Surg; 2003 Jun; 111(7):2273-85. PubMed ID: 12794470
[TBL] [Abstract][Full Text] [Related]
10. Metalloproteinase expression is associated with traumatic wound failure.
Utz ER; Elster EA; Tadaki DK; Gage F; Perdue PW; Forsberg JA; Stojadinovic A; Hawksworth JS; Brown TS
J Surg Res; 2010 Apr; 159(2):633-9. PubMed ID: 20056248
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases in wound repair (review).
Ravanti L; Kähäri VM
Int J Mol Med; 2000 Oct; 6(4):391-407. PubMed ID: 10998429
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix-metalloproteases in the fluid of chronic diabetic foot wounds treated with a protease absorbent dressing.
Motzkau M; Tautenhahn J; Lehnert H; Lobmann R
Exp Clin Endocrinol Diabetes; 2011 May; 119(5):286-90. PubMed ID: 21031342
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.
Lobmann R; Ambrosch A; Schultz G; Waldmann K; Schiweck S; Lehnert H
Diabetologia; 2002 Jul; 45(7):1011-6. PubMed ID: 12136400
[TBL] [Abstract][Full Text] [Related]
14. The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing.
McCarty SM; Cochrane CA; Clegg PD; Percival SL
Wound Repair Regen; 2012; 20(2):125-36. PubMed ID: 22380687
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds.
Agren MS
Arch Dermatol Res; 1999 Nov; 291(11):583-90. PubMed ID: 10638331
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
Madlener M; Parks WC; Werner S
Exp Cell Res; 1998 Jul; 242(1):201-10. PubMed ID: 9665817
[TBL] [Abstract][Full Text] [Related]
17. An analysis of replicative senescence in dermal fibroblasts derived from chronic leg wounds predicts that telomerase therapy would fail to reverse their disease-specific cellular and proteolytic phenotype.
Stephens P; Cook H; Hilton J; Jones CJ; Haughton MF; Wyllie FS; Skinner JW; Harding KG; Kipling D; Thomas DW
Exp Cell Res; 2003 Feb; 283(1):22-35. PubMed ID: 12565817
[TBL] [Abstract][Full Text] [Related]
18. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
19. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity.
Cook H; Davies KJ; Harding KG; Thomas DW
J Invest Dermatol; 2000 Aug; 115(2):225-33. PubMed ID: 10951240
[TBL] [Abstract][Full Text] [Related]
20. The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.
Ayuk SM; Abrahamse H; Houreld NN
J Diabetes Res; 2016; 2016():2897656. PubMed ID: 27314046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
